- Home
- TONX vs OVID Comparison
TONX vs OVID Comparison
Compare TONX & OVID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TONX | OVID |
|---|---|---|
| Founded | N/A | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 136.5M | 117.5M |
| IPO Year | N/A | 2017 |
Fundamental Metrics
Financial Performance| Metric | TONX | OVID |
|---|---|---|
| Price | $1.96 | $1.60 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $3.40 |
| AVG Volume (30 Days) | 493.0K | ★ 1.7M |
| Earning Date | 03-24-2026 | 03-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 7.29 | N/A |
| Revenue | ★ $7,760,000.00 | $6,610,000.00 |
| Revenue This Year | $526.82 | $1,077.56 |
| Revenue Next Year | $45.45 | N/A |
| P/E Ratio | $0.27 | ★ N/A |
| Revenue Growth | ★ 3760.70 | 945.89 |
| 52 Week Low | $1.78 | $0.24 |
| 52 Week High | $29.77 | $2.01 |
Technical Indicators
Market Signals| Indicator | TONX | OVID |
|---|---|---|
| Relative Strength Index (RSI) | 29.15 | 42.14 |
| Support Level | $1.78 | $1.40 |
| Resistance Level | $2.70 | $1.61 |
| Average True Range (ATR) | 0.22 | 0.12 |
| MACD | -0.09 | -0.02 |
| Stochastic Oscillator | 8.84 | 15.91 |
Price Performance
Historical ComparisonAbout TONX TON Strategy Company
TON Strategy Co is a leader in interactive video-based sales applications, transforms how businesses attract and engage customers. The company's Software-as-a-Service platform, based on its proprietary interactive video technology, comprises a suite of easy-to-use, subscription-based sales enablement software products. The segments of the company are MARKET.live and Go Fund Yourself, and it derives maximum revenue from MARKET.live segment.
About OVID Ovid Therapeutics Inc.
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.